REGENXBIO Inc.
NASDAQREGENXBIO heads into its May 14 earnings release with short sellers slowly backing away — but by no means conceding the debate. Short interest tells the headline story. At 13.1% of free float, the short position is substantial by any measure. It has declined steadily, however — down roughly 5% over the past week and 4% in a single session on May 11, following a month where the…
Snapshot as of 25 Jun 2026
REGENXBIO heads into its May 14 earnings release with short sellers slowly backing away — but by no means conceding the debate. Short interest tells the headline story. At 13.1% of free float, the short position is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RGNX — free to start on ORTEX.
Sign up for free →Open RGNX on ORTEX